Foresight to Initiate First Pilot Project for Its COVID-19 Symptom Detection Solution
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision, announced today that it will begin a pilot project for its prototype COVID-19 symptom detection mass screening solution.
- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision, announced today that it will begin a pilot project for its prototype COVID-19 symptom detection mass screening solution.
- The pilot project will be carried out in Meuhedets largest clinic in Ashdod which serves approximately 50,000 patients.
- This first pilot project with a leading Israeli HMO validates the need for Foresights new screening solution in high-traffic areas such as health clinics.
- For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.foresightauto.com , follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn.